Results 181 to 190 of about 4,984,986 (258)

Adverse perinatal outcomes indicative of RhD-mediated hemolytic disease of the fetus and newborn in Eastern Ethiopia: evidence of maternal health inequity in a multicenter cohort study. [PDF]

AJOG Glob Rep
Desalew A, van der Schoot CE, Mjema RN, van den Akker T, Vermeiden T, Schonewille H, Pyuza JJ, Gure T, Verweij EJTJ, Tura AK.   +9 more
europepmc   +1 more source

Hemolytic uremic syndrome post-diarrheal: (Week 25) Weekly cases* of notifiable diseases, United States, U.S. Territories, and Non-U.S. Residents week ending June 24, 2023

This data includes weekly cases of notifiable diseases, United States, U.S. Territories, and Non-U.S. Residents, specifically covering Hemolytic uremic syndrome post-diarrheal cases. The Weekly data are considered provisional and collected locally due to

core  

Noninvasive Diagnosis of Splenosis Using Tc‐99m Heat‐Denatured Red Blood Cell Scintigraphy

American Journal of Hematology, EarlyView.
Natacha Dewarrat, Katharina Auf der Springe, Francesco Grandoni, Rami Hajri, Mathilde Gavillet   +4 more
wiley   +1 more source

ANK1 and EPB41 Variants and The Risk of Glucocorticoid‐Induced Osteonecrosis

Arthritis &Rheumatology, EarlyView.
Objective Steroid‐induced osteonecrosis of the femoral head (SONFH) is a refractory skeletal disorder influenced by genetic and environmental factors. However, conclusive pathogenic genetic evidence remains elusive due to the limited exploration of rare damaging variants. In this study, we aimed to identify rare variants associated with SONFH.
Shengbao Chen, Xianmin Zhu, Zhongzhong Chen, Wei Chen, Hussam Alkaissi, Zeng Zhang, Yun Gao, Junhui Yin, Xiangtian Yu, Qiong Fu, Youshui Gao, Zhenzhong Zhu, Qianying Cai, Pengwei Zhang, Weibin Chen, Xin Zhao, Xiaojin Wu, Karel Pacak, Dongxu Jin, Chunde Bao, Zhengping Zhuang, Changqing Zhang   +21 more
wiley   +1 more source

Global burden of hemolytic disease and neonatal jaundice from 1990 to 2021 with projections to 2050: a systematic analysis of the GBD 2021 data. [PDF]

BMC Pediatr
Huang K, Gao B, Zhang L, Xiao M.
europepmc   +1 more source

Hemolytic uremic syndrome post-diarrheal: (Week 38) Weekly cases* of notifiable diseases, United States, U.S. Territories, and Non-U.S. Residents week ending September 23, 2023

This data includes weekly cases of notifiable diseases, United States, U.S. Territories, and Non-U.S. Residents, specifically covering Hemolytic uremic syndrome post-diarrheal cases. The Weekly data are considered provisional and collected locally due to

core  

From Interferon Signature to the Clinical Landscape: Type I Interferonopathies

Arthritis &Rheumatology, EarlyView.
Objective TypeI interferonopathies are heterogeneous diseases driven by dysregulated type I interferon (IFN‐I) signaling. Diagnosis is challenging due to clinical/molecular variability and the need for IFN‐I quantification. The aim of this study was to characterize the clinical, immunologic, genetic, molecular profiles of patients with suspected ...
Ismail Yaz, Seza Ozen, Hacer Neslihan Bildik, Canberk Ipsir, Dilara Unal, Saliha Esenboga, Begum Cicek, Mehmet Emin Seker, Fatima Aerts‐Kaya, Seher Sener, Mehmet Orhan Erkan, Hanife Avci, Deniz Cagdas, Ilhan Tezcan   +13 more
wiley   +1 more source

Perinatal Hemolytic Disease Due to Anti-Jkb: A Case Report. [PDF]

Cureus
Bandeira FM, Mesquita CA, Fonseca KB, Magalhães HP, Silva SAF, Silva FS.   +5 more
europepmc   +1 more source

Hemolytic uremic syndrome post-diarrheal: (Week 47) Weekly cases* of notifiable diseases, United States, U.S. Territories, and Non-U.S. Residents week ending November 25, 2023

Hemolytic uremic syndrome post-diarrheal cases. The Weekly data are considered provisional and collected locally due to state, territorial, and local regulations.

core  

Pharmacometric evaluation of pre‐referral rectal artesunate in children with severe malaria

British Journal of Clinical Pharmacology, EarlyView.
Aims Parenteral artesunate is the preferred first‐line treatment for severe malaria. Pre‐referral rectal artesunate suppositories are recommended where parenteral treatment is inaccessible. In this study, we compared dihydroartemisinin exposure and model‐predicted early parasite clearance following rectal artesunate and intravenous artesunate in ...
Ayorinde Adehin, Marie A. Onyamboko, Caterina Fanello, Nicholas J. White, Nicholas P. J. Day, Richard M. Hoglund, Joel Tarning   +6 more
wiley   +1 more source